Vojtĕsek B - Search Results

1

Overexpression of p53 and MDM2 proteins in cervical neoplasia.

Lukás Z, Vojtĕsek B, Anton M, Picksley SM, Kubálek V. Lukás Z, et al. Among authors: vojtesek b. Folia Biol (Praha). 1995;41(3-4):197-9. Folia Biol (Praha). 1995. PMID: 7589715

2

p53 protein alterations in human testicular cancer including pre-invasive intratubular germ-cell neoplasia.

Bártková J, Bártek J, Lukás J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Midgley CA, Lane DP. Bártková J, et al. Among authors: vojtesek b. Int J Cancer. 1991 Sep 9;49(2):196-202. doi: 10.1002/ijc.2910490209. Int J Cancer. 1991. PMID: 1652567

3

Effects of tissue fixation conditions and protease pretreatment on immunohistochemical performance of a large series of new anti-keratin monoclonal antibodies: value in oncopathology.

Bártková J, Bártek J, Lukás Z, Vojtĕsek B, Stasková Z, Bursová H, Pavlovská R, Rejthar A, Kovarík J. Bártková J, et al. Among authors: vojtesek b. Neoplasma. 1991;38(4):439-46. Neoplasma. 1991. PMID: 1717857

4

Aberrant expression of the p53 oncoprotein is a common feature of a wide spectrum of human malignancies.

Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Lukás J, Rejthar A, Kovarík J, Midgley CA, Gannon JV, Lane DP. Bártek J, et al. Among authors: vojtesek b. Oncogene. 1991 Sep;6(9):1699-703. Oncogene. 1991. PMID: 1923535

5

Patterns of expression of the p53 tumour suppressor in human breast tissues and tumours in situ and in vitro.

Bártek J, Bártková J, Vojtĕsek B, Stasková Z, Rejthar A, Kovarík J, Lane DP. Bártek J, et al. Among authors: vojtesek b. Int J Cancer. 1990 Nov 15;46(5):839-44. doi: 10.1002/ijc.2910460515. Int J Cancer. 1990. PMID: 2228312

6

Differential expression of keratin 19 in normal human epithelial tissues revealed by monospecific monoclonal antibodies.

Bártek J, Bártková J, Taylor-Papadimitriou J, Rejthar A, Kovarík J, Lukás Z, Vojtĕsek B. Bártek J, et al. Among authors: vojtesek b. Histochem J. 1986 Oct;18(10):565-75. doi: 10.1007/BF01675198. Histochem J. 1986. PMID: 2433255

7

On the regulation of the p53 tumour suppressor, and its role in the cellular response to DNA damage.

Lane DP, Midgley CA, Hupp TR, Lu X, Vojtesek B, Picksley SM. Lane DP, et al. Among authors: vojtesek b. Philos Trans R Soc Lond B Biol Sci. 1995 Jan 30;347(1319):83-7. doi: 10.1098/rstb.1995.0013. Philos Trans R Soc Lond B Biol Sci. 1995. PMID: 7746859 Review.

8

Immunochemical analysis of the interaction of p53 with MDM2;--fine mapping of the MDM2 binding site on p53 using synthetic peptides.

Picksley SM, Vojtesek B, Sparks A, Lane DP. Picksley SM, et al. Among authors: vojtesek b. Oncogene. 1994 Sep;9(9):2523-9. Oncogene. 1994. PMID: 8058315

9

p53 protein overexpression associates with growth patterns rather than with metastasizing in operable breast cancer.

Vojtĕsek B, Kovarík J, Nenutil R, Svitáková M, Zaloudík J, Dolezalová H, Rejthar A, Lauerová L. Vojtĕsek B, et al. Neoplasma. 1995;42(6):331-6. Neoplasma. 1995. PMID: 8592576

10

Epitope analysis of the murine p53 tumour suppressor protein.

Lane DP, Stephen CW, Midgley CA, Sparks A, Hupp TR, Daniels DA, Greaves R, Reid A, Vojtesek B, Picksley SM. Lane DP, et al. Among authors: vojtesek b. Oncogene. 1996 Jun 6;12(11):2461-6. Oncogene. 1996. PMID: 8649788

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page